What is unlikely at this stage: Visible muscle changes, scale weight gain, or measurable strength shifts
The compound has been studied in rodent models of tendon transection, ligament injury, bone fracture, and muscle crush with findings that have attracted attention from sports medicine researchers, orthopedic scientists, and the broader athletic research applications community
When low-and-slow dosing (or staying at the starting dose) makes sense and why not everyone needs aggressive escalation
Boucher, W., Kempuraj, D., Michaelian, M
If you are struggling with side effects from GLP-1s or are not able to reach your glycemic goals, you may want to consider speaking with a healthcare provider about a fixed-ratio combination drug like Xultophy or Soliqua and whether it could be a fit for you
Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: A role of lipid mobilization and inflammation